167 related articles for article (PubMed ID: 24746516)
1. β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma.
Wan Y; Zhao W; Jiang Y; Liu D; Meng G; Cai Y
Hum Pathol; 2014 Jul; 45(7):1459-65. PubMed ID: 24746516
[TBL] [Abstract][Full Text] [Related]
2. Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma.
Hosono A; Yamaguchi U; Makimoto A; Endo M; Watanabe A; Shimoda T; Kaya M; Matsumura T; Sonobe H; Kusumi T; Yamaguchi T; Hasegawa T
J Clin Pathol; 2007 Apr; 60(4):410-4. PubMed ID: 16822878
[TBL] [Abstract][Full Text] [Related]
3. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
4. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
6. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of N-cadherin and β-catenin protein in osteosarcoma].
Yang JZ; Zhang XH; Liu JR; Ding Y; Gao F; Wang Y
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):586-9. PubMed ID: 21122409
[TBL] [Abstract][Full Text] [Related]
8. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
9. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
10. Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma.
McHugh KE; Reith JD; Lucas DR; Emory CL; Mesko NW; Kilpatrick SE
Am J Surg Pathol; 2019 May; 43(5):610-617. PubMed ID: 30807304
[TBL] [Abstract][Full Text] [Related]
11. Osteogenic tumors of bone.
Green JT; Mills AM
Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
13. Benign osteoblastoma in an unusual mastoid location.
Njim L; Dhouibi A; Touil N; Lahmar I; Hadhri R; Moussa A; Zakhama A
Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Nov; 127(5):183-5. PubMed ID: 20951662
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin expression in skeletal sarcomas.
Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastoma: a study of 12 cases.
Jambhekar NA; Desai S; Khapake D
Indian J Pathol Microbiol; 2006 Oct; 49(4):487-90. PubMed ID: 17183834
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
17. Bone-Forming Tumors.
Zhang Y; Rosenberg AE
Surg Pathol Clin; 2017 Sep; 10(3):513-535. PubMed ID: 28797500
[TBL] [Abstract][Full Text] [Related]
18. beta-Catenin and met deregulation in childhood Hepatoblastomas.
Ranganathan S; Tan X; Monga SP
Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.
Haydon RC; Deyrup A; Ishikawa A; Heck R; Jiang W; Zhou L; Feng T; King D; Cheng H; Breyer B; Peabody T; Simon MA; Montag AG; He TC
Int J Cancer; 2002 Dec; 102(4):338-42. PubMed ID: 12402302
[TBL] [Abstract][Full Text] [Related]
20. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]